J Pediatr Hematol Oncol
Dr. Birte Wistinghausen, MD
- Publications
- 27
- Clinical trials
- 10
- Hospital affiliations
- 1
- Industry payments
- $108
- Medical group
- 1
- Practice address
- 111 Michigan Ave, NW, Washington, DC 20010
- Practice phone
- Call (202) 476-5000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Wistinghausen's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Birte Wistinghausen is a pediatric hematology and oncology physician in Washington, District of Columbia
Dr. Wistinghausen practices at Children's National Hospital in Washington, District of Columbia, part of Children's National Hospital.
Dr. Wistinghausen's NPI, 1043314784, was assigned on September 12, 2006. Dr. Wistinghausen holds New York license 215640.
- NPI
- 1043314784NPI Registry (opens in a new tab)
- NPI enumeration date
- September 12, 2006
- NPI status
- Active
- Practice phone
- (202) 476-5000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Birte Wistinghausen practices at Children's National Hospital in Washington, District of Columbia
Dr. Wistinghausen's primary practice is Children's National Hospital, at 111 Michigan Ave, NW, Washington, DC 20010 in The District County. The practice phone is (202) 476-5000.
- Children's National Hospital111 Michigan Ave, NW, Washington, DC 20010 · The District CountyPhone(202) 476-5000
Source: Dmand AI Affiliation Data
Dr. Birte Wistinghausen is affiliated with 2 sites of care and 1 medical group
Dr. Wistinghausen's primary practice is Children's National Hospital in Washington, District of Columbia, part of Children's National Hospital. The medical group on file is Children's National Hospital. Dmand AI also links Dr. Wistinghausen to 1 more dialysis center, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Birte Wistinghausen's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wistinghausen practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Children's National Hospital | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Children's National Hospital and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Birte Wistinghausen is one of 65 pediatric hematologys and oncology physicians in District of Columbia
Pediatric hematology-oncology is Dr. Wistinghausen's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Wistinghausen is licensed in New York.
Specialties and state licenses
- Pediatric hematology and oncology, New YorkPrimary
Pediatric hematologys and oncology physicians near Dr. Wistinghausen
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Birte Wistinghausen's patients have a median age of 10
Across all payers, Dmand AI patient panel data puts Dr. Wistinghausen's median patient age at 10, with 49% women.
Dr. Wistinghausen's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 10
Patient panel by sex, all payers
- Women49%
- Men51%
Source: Dmand AI Patient Panel Data
Dr. Birte Wistinghausen has 27 publications on record
Dmand AI links 27 papers to Dr. Wistinghausen, published from 2010 to 2024. 2024 was the busiest year, with 8. The most frequent topics are Epstein-Barr Virus Infections, Lymphoproliferative Disorders and Herpesvirus 4, Human. Dr. Wistinghausen has published most often in Pediatr Blood Cancer. Dr. Wistinghausen's most frequent co-authors are Michelle L. Hermiston, MD, Keri Toner, MD and Carl E. Allen, MD.
Dr. Wistinghausen's papers by year, 2011 to 2024
Topics Dr. Wistinghausen writes about most
- Epstein-Barr Virus Infections
- Lymphoproliferative Disorders
- Herpesvirus 4, Human
- Hematopoietic Stem Cell Transplantation
- Organ Transplantation
- Postoperative Complications
- Histiocytosis, Langerhans-Cell
- Immunosuppression Therapy
Dr. Wistinghausen's most frequent co-authors
- Michelle L. Hermiston, MD5 shared papers
- Keri Toner, MD5 shared papers
- Carl E. Allen, MD4 shared papers
Recent publications by Dr. Wistinghausen
J Child Neurol
Pediatr Blood Cancer
See who Dr. Wistinghausen researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Wistinghausen works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Birte Wistinghausen has worked on 10 clinical trials
Dmand AI links Dr. Wistinghausen to 10 clinical trials, 7 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Ganglioneuroblastoma, Neuroblastoma and Angiolipoma. National Cancer Institute (NCI) sponsors the most, 6.
Clinical trials with Dr. Wistinghausen by phase
- NonePhase 1: no trials
- NonePhase 2: no trials
- 1Phase 2/3: 1 trial
- 7Phase 3: 7 trials
- NonePhase 4: no trials
Conditions in Dr. Wistinghausen's trials
- Ganglioneuroblastoma
- Neuroblastoma
- Angiolipoma
- Burkitt Lymphoma
- Chondrosarcoma, Mesenchymal
Investigators on the most trials with Dr. Wistinghausen
- Vikramjit Singh Kanwar, MBA, MD9 shared trials
- Wendy L. Woods-Swafford, MD9 shared trials
- Peter D. Cole, MD8 shared trials
Recent clinical trials with Dr. Wistinghausen
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) (opens in a new tab)
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma (opens in a new tab)
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma (opens in a new tab)
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma (opens in a new tab)
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Birte Wistinghausen received $108 in industry payments in 2020
CMS Open Payments shows 1 general payment to Dr. Wistinghausen from 1 drug or device company in 2020. Entertainment make up the largest share, 100% of the total. Eurofins Viracor, LLC paid the most, $108.
Companies that paid Dr. Wistinghausen the most, 2020 to 2020
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Birte Wistinghausen's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Birte Wistinghausen
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Birte Wistinghausen's NPI number?
Dr. Birte Wistinghausen's NPI number is 1043314784. It was assigned on September 12, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Birte Wistinghausen?
Dr. Birte Wistinghausen is a pediatric hematology and oncology physician in Washington, District of Columbia. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Birte Wistinghausen practice?
Dr. Wistinghausen practices at 111 Michigan Ave, NW, Washington, DC 20010. Dr. Wistinghausen's primary practice is Children's National Hospital in Washington, District of Columbia, part of Children's National Hospital. Dmand AI also links Dr. Wistinghausen to 1 dialysis center.
What is Dr. Birte Wistinghausen's office phone number?
The practice phone on file for Dr. Wistinghausen is (202) 476-5000.
What is Dr. Birte Wistinghausen's medical license number?
Dr. Wistinghausen holds New York license 215640.
Which hospitals is Dr. Birte Wistinghausen affiliated with?
Dr. Wistinghausen practices at Children's National Hospital in Washington, District of Columbia.
What medical group is Dr. Birte Wistinghausen part of?
Dr. Wistinghausen is linked to Children's National Hospital.
Has Dr. Birte Wistinghausen received payments from drug or device companies?
CMS Open Payments shows $108 in general payments to Dr. Wistinghausen from 1 company from 2020 to 2020. The largest total came from Eurofins Viracor, LLC.
How long has Dr. Birte Wistinghausen been practicing?
Dr. Wistinghausen's NPI was assigned in 2006.
Does Dr. Birte Wistinghausen do research?
Dmand AI links 27 publications to Dr. Wistinghausen, published from 2010 to 2024. Dr. Wistinghausen has worked on 10 clinical trials.
Who does Dr. Birte Wistinghausen publish with?
Dr. Wistinghausen's most frequent co-authors are Michelle L. Hermiston, MD (5 shared papers), Keri Toner, MD (5 shared papers) and Carl E. Allen, MD (4 shared papers).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in District of Columbia by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card